63家！中国生物制造500+代表性企业榜单（京津冀篇）, 建议收藏!

Core Insights - The article highlights the strategic development and policy support for the synthetic biology manufacturing industry in the Beijing-Tianjin-Hebei region, emphasizing its collaborative advantages and global competitiveness potential [2][3]. Policy Support and Innovation Mechanisms - Significant policy support has been established, creating a collaborative innovation mechanism among the three regions [4]. - The regions have formed a gradient layout: R&D in Beijing, pilot testing in Tianjin, and industrialization in Hebei [3]. Regional Industrial Layout - Beijing serves as the innovation source, while Tianjin focuses on industrial transformation and manufacturing, particularly in the Binhai New Area, which is developing a "Biomanufacturing Valley" [5]. - Hebei is positioned for low-cost production and supporting industries, with a focus on self-sufficient industrial chains [6]. Financial and Research Support - A joint basic research cooperation project will be established by 2025, with individual project funding up to 600,000 yuan to support synthetic biology manufacturing [8]. - Beijing's action plan aims to accelerate innovation in synthetic biology, with a maximum support of 50 million yuan to cultivate three listed companies by 2026 [8]. Industry Growth Targets - Hebei's Shijiazhuang aims for the biomanufacturing industry revenue to exceed 150 billion yuan by 2025, focusing on gene synthesis and biobased materials [8]. - The industry scale in Yizhuang is expected to surpass 120 billion yuan by 2027, with policies supporting cutting-edge sectors [8]. Upcoming Events and Initiatives - The Fourth Synthetic Biology and Green Biomanufacturing Conference will be held from August 20-22, 2025, in Ningbo, focusing on AI and biomanufacturing, green chemistry, and new materials [17][19]. - The conference will feature various forums and discussions aimed at advancing the industry and showcasing technological achievements [17][19].